Multimodal deep learning for immunotherapy response prediction and biomarker discovery in non-small cell lung cancer
Journal of the American Medical Informatics Association · 2025
DOI: 10.1093/jamia/ocaf142 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Medical Informatics Association, 2025. Verfasst von Zijun Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Academy of Artificial Intelligence, Beijing Institute of Petrochemical Technology, 19 Qingyuan North Road, Daxing District, Beijing 102617, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Deep Learning, Immunotherapy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Beijing Municipal Education Commission, Climbing Program Foundation.
Abstract (Originalsprache)
Objective
Immunotherapy has emerged as a promising treatment for advanced non-small cell lung cancer (NSCLC), but accurately predicting which patients will benefit from it remains a major clinical challenge. To address this, we aim to develop a novel multimodal method, DeepAFM, that integrates histopathology, genomic features, and clinical information to predict patient responses to anti-PD-(L)1 immunotherapy. Materials and Methods A total of 93 patients with advanced NSCLC were included in this study. Histopathological whole-slide images were processed using a self-supervised VQVAE2 for representation learning. PCA and K-means clustering were then applied for dimensionality reduction and feature grouping. Key regions of interest were visualized through permutation importance evaluation and color-coding techniques. The extracted histopathological features, along with genomic alterations and clinical variables, were integrated into the DeepAFM multimodal prediction model.
Results
The DeepAFM achieved a high predictive performance with an area under the curve (AUC) of 0.77 (95% confidence interval: 0.69-1.00). Attention-based heatmaps revealed that the model could identify critical pathological patterns, genomic mutations, and clinical indicators associated with patient responses to immunotherapy.
Discussion
The integration of multimodal data enabled the model to capture complex interactions among pathology, genomics, and clinical characteristics, enhancing the interpretability and predictive power of immunotherapy response prediction. The visualization techniques facilitated the identification of biologically meaningful features and potential biomarkers.
Conclusion
This study demonstrates the effectiveness of the DeepAFM in predicting responses to immunotherapy in advanced NSCLC. The approach not only improves prediction accuracy but also provides valuable insights for personalized treatment strategies and biomarker discovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Academy of Artificial Intelligence, Beijing Institute of Petrochemical Technology, 19 Qingyuan North Road, Daxing District, Beijing 102617, China.
ORCID-Profile: Chaojing Shi, Qianjin Guo
Förderung
- National Natural Science Foundation of China
- Beijing Municipal Education Commission
- Climbing Program Foundation
- ZhiYuan Fund Key Project of Beijing Institute of Petrochemical Technology
Zitieren
APA
Wang, Z., Liu, X., Han, K., Lei, L., Shi, C., Liu, W., & Guo, Q. (2025). Multimodal deep learning for immunotherapy response prediction and biomarker discovery in non-small cell lung cancer. Journal of the American Medical Informatics Association. https://doi.org/10.1093/jamia/ocaf142
Vancouver
Wang Z, Liu X, Han K, Lei L, Shi C, Liu W, et al. Multimodal deep learning for immunotherapy response prediction and biomarker discovery in non-small cell lung cancer. Journal of the American Medical Informatics Association. 2025. doi:10.1093/jamia/ocaf142
BibTeX
@article{Wang2025,
author = {Wang, Zijun and Liu, Xi and Han, Kaitai and Lei, Lixin and Shi, Chaojing and Liu, Wu and Guo, Qianjin},
title = {Multimodal deep learning for immunotherapy response prediction and biomarker discovery in non-small cell lung cancer},
journal = {Journal of the American Medical Informatics Association},
year = {2025},
doi = {10.1093/jamia/ocaf142}
}
EUVIMED